Viewing Study NCT01623102


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2026-03-01 @ 5:40 PM
Study NCT ID: NCT01623102
Status: UNKNOWN
Last Update Posted: 2013-02-12
First Post: 2012-06-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer
Sponsor: Sichuan Cancer Hospital and Research Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bevacizumab View
None gemcitabine View
None cisplatin View
None EGFR wild-type View